From the Desk of Dr. Lenz

Aspirin for Every Patient with Metastatic Colon Cancer?

A recent study suggested that patients with colon cancer lived longer when taking aspirin.

Aspirin is a very interesting drug which has showed to reduce the risk of cardiovascular disease and colon cancer risk and is a great pain reliever. The mechanism of action is the inhibition of an enzyme called COX-2.

However aspirin also inhibits COX-1 which is thought to be responsible for some of its side effects such as stomach ulcers, bleeding disorders and kidney problems. Therefore major pharmaceutical companies have developed specific COX-2 inhibitors to have the great benefits but not the side effects. These drugs are known as Celebrex and Vioxx.

It was shocking to see the results from the large VICTOR trial testing Vioxx in patients with colon cancer who had successful resection and adjuvant chemotherapy. This trial enrolled 1167 patients and 23 cardiovascular thrombotic events occurred (heart attacks), 16 were in the Vioxx group and 7 in the placebo group. Statistically this was highly significant making it an estimated risk of 2.66 which means increase by 266 percent. These data were the end of the COX-2 inhibitors in the chemoprevention world.

The newest study on aspirin shows clearly that the inhibition of these enzymes may benefit patients with active disease. Dr. Chan showed in 1300 patients with colon cancer were nearly 30% less likely to die from their cancer.

How aspirin works, we don’t know. It can prevent blood clots, but COX-2 is directly involved in inflammation which can be part of cancer, and invasion and metastases. These data warrant further studies of the role of these drugs for patients with colon cancer.

I discuss and use baby aspirin  for many of my patients but also let them know about the potential risk factors. For example someone with bleeding problems or stomach ulcer or kidney function problems would be not great candidate. However for patients on Avastin I do consider aspirin to potentially reduce the risk for heart attack and strokes.

Please discuss these findings with your treating oncologists.

Bookmark and Share

This news article was originally posted on August 31st, 2009 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Heinz-Josef Lenz, MD on August 31st, 2009
Tags: aspirin, chemoprevention, survival, Treating Colorectal Cancer

Comments

Jerryl

September 9, 2009 at 4:12pm

Dr. Lenz
My husband was recently diagnosed with stage IV colon cancer with mets to the liver and is on Avastin. His oncologist recommended that he avoid aspirin because of the liver involvement. Is this medicinal dose of aspirin OK for him?

Heinz-Josef Lenz

September 9, 2009 at 4:26pm

it should be but as you can imagine dont know the full history or medical issues of your husband, but some physicians even use aspirin to reduce risks of heart attacks and strokes associated with avastin, if his liver function is not good leading to increased bleeding, aspirin should not be given, please clarify with your oncologist. HJL

Michael Grinberg, M.D.

September 10, 2009 at 2:45pm

Could you please cite Dr. Chan’s original article you referred to and rely upon?

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

From the Desk of Dr. Lenz

This blog is published for general patient education only. You are welcome to leave comments on his posts, however individual medical advice will not be provided.

We urge you to consult directly with your physician for diagnosis and for answers to your personal questions based on your unique medical history.

The views and opinions expressed on Dr. Lenz's blog are his own and do not necessarily represent the views and opinions of C3: Colorectal Cancer Coalition.

Who is Dr. Lenz?

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe